ADALIMUMAB DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION

Objective: to assess whether adalimumab (AD) can be gradually discontinued during continuous methotrexate (MTX) use in patients with early rheumatoid arthritis (ERA).Subjects and methods. Within the REMARCA (the Russian study of methotrexate and biological agents in early active arthritis) study, th...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: N. V. Demidova, E. A. Galushko, S. I. Glukhova, N. M. Savushkina, A. M. Satybaldyev, M. V. Cherkasova, N. V. Khoroshko, S. V. Maglevanyi, A. V. Gordeev
Fformat: Artigo
Iaith:Russo
Cyhoeddwyd: IMA-PRESS LLC 2018-07-01
Cyfres:Научно-практическая ревматология
Pynciau:
early rheumatoid arthritis
adalimumab
remission
Mynediad Ar-lein:https://rsp.mediar-press.net/rsp/article/view/2565
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg